GenMont Biotech Incorporation
3164
Rank in Stocks
#23293
Based in Taiwan, GenMont Biotech Incorporation is primarily engaged in the... Based in Taiwan, GenMont Biotech Incorporation is primarily engaged in the comprehensive process of developing, manufacturing, and marketing functional probiotic products. Beyond its core offerings, the company also provides specialized probiotic formulations. It extends its services to include original formula design and production for health-oriented food items, as well as supplying relevant manufacturing equipment. Additionally, GenMont Biotech actively collaborates on the research, production, and clinical evaluation of a variety of other products. The company was established in 2000 and has its headquarters situated in Tainan City, Taiwan.
Share Price
$0.50604201
Last synced: 2026-11-10
Market Cap
$43.52M
Change (1 day)
-0.30%
Change (1 year)
-14.99%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade GenMont Biotech Incorporation (3164)
Category
Healthcare
EPS for GenMont Biotech Incorporation (3164)
EPS as of June 2026 TTM: $0.03
According to GenMont Biotech Incorporation's latest financial reports, its current EPS (TTM) is $0.03. At the end of 2025 the company had an EPS of $0.02, equal to its 2024 EPS of $0.02.
EPS history for GenMont Biotech Incorporation from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.03 | 25.00% |
| 2025 | $0.02 | 4.48% |
| 2024 | $0.02 | 62.10% |
| 2023 | $0.01 | -42.33% |
| 2022 | $0.02 | -54.55% |
| 2021 | $0.05 | 92.28% |
| 2020 | $0.02 | 13.36% |
| 2019 | $0.02 | -62.71% |
| 2018 | $0.06 | 238.37% |
| 2017 | $0.02 | -121.05% |
| 2016 | $-0.08 | 144.61% |
| 2015 | $-0.03 | -81.80% |
| 2014 | $-0.18 | -1,173.10% |
| 2013 | $0.02 | -4.47% |
| 2012 | $0.02 | -24.79% |
| 2011 | $0.02 | -75.05% |
| 2010 | $0.10 | 88.17% |
| 2009 | $0.05 | 67.88% |
| 2008 | $0.03 | -15.64% |
| 2007 | $0.04 | 364.94% |
| 2006 | $0.01 | -191.67% |
| 2005 | $-0.01 | -78.52% |
| 2004 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 62,540.00% |
US
|
|
| $-7.07 | -28,380.00% |
US
|
|
| $-5.29 | -21,260.00% |
AU
|
|
| $12.88 | 51,420.40% |
BE
|
|
| $21.56 | 86,140.00% |
NL
|
Questions about GenMont Biotech Incorporation's earnings per share (EPS)
What is GenMont Biotech Incorporation's earnings per share (EPS)?
GenMont Biotech Incorporation's earnings per share (EPS) over the last twelve months is $0.03, as of Jun 2026.
What was GenMont Biotech Incorporation's earnings per share (EPS) in 2025?
In 2025, GenMont Biotech Incorporation's earnings per share (EPS) was $0.02, about the same as in 2024 ($0.02).
How has GenMont Biotech Incorporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, GenMont Biotech Incorporation's earnings per share (EPS) went from $0.02 to $0.02, an average growth of 0.00% a year.
How does GenMont Biotech Incorporation's earnings per share (EPS) compare with similar companies?
GenMont Biotech Incorporation's earnings per share (EPS) ($0.03) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.